Yves Sagot
Director/Board Member chez BIOSENIC SA
Profil
Yves Sagot was the founder of RELIEF THERAPEUTICS Holding SA, where he held the title of Chief Scientific Officer from 2016 to 2020.
He is also the founder of Sonnet BioTherapeutics CH SA. Currently, Dr. Sagot is an Independent Director at BioSenic SA since 2023.
Dr. Sagot has a graduate and doctorate degree from the University of Geneva and a doctorate degree from Université Toulouse III - Paul Sabatier.
Postes actifs de Yves Sagot
| Sociétés | Poste | Début |
|---|---|---|
| BIOSENIC SA | Director/Board Member | 27/01/2023 |
Anciens postes connus de Yves Sagot
| Sociétés | Poste | Fin |
|---|---|---|
| RELIEF THERAPEUTICS HOLDING SA | Founder | 08/10/2020 |
Sonnet BioTherapeutics CH SA
 Sonnet BioTherapeutics CH SA Pharmaceuticals: MajorHealth Technology Sonnet BioTherapeutics CH SA develops cure for peripheral neuropathies. The company was founded by Michel Dreano and Gael Hédou in 2013 and is headquartered in Geneve, Switzerland. | Founder | - |
Formation de Yves Sagot
| University of Geneva | Doctorate Degree |
| Université Toulouse III - Paul Sabatier | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| RELIEF THERAPEUTICS HOLDING SA | Health Technology |
| BIOSENIC SA | Health Technology |
| Entreprise privées | 1 |
|---|---|
Sonnet BioTherapeutics CH SA
Sonnet BioTherapeutics CH SA Pharmaceuticals: MajorHealth Technology Sonnet BioTherapeutics CH SA develops cure for peripheral neuropathies. The company was founded by Michel Dreano and Gael Hédou in 2013 and is headquartered in Geneve, Switzerland. | Health Technology |
